These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New class PCSK9 blockers stride into cholesterol market. Sheridan C Nat Biotechnol; 2015 Aug; 33(8):785-6. PubMed ID: 26252118 [No Abstract] [Full Text] [Related]
3. PCSK9 Inhibitors May Show Benefits of Ultra-Low LDL Levels. Reinke T Manag Care; 2015 Aug; 24(8):13-4. PubMed ID: 26399135 [No Abstract] [Full Text] [Related]
4. [PCSK9 inhibitors: emerging treatment to lower cholesterol?]. Gencer B; Rodondi N; Mach F Rev Med Suisse; 2014 Mar; 10(420):539-42, 544. PubMed ID: 24701672 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of PCSK9: is this the way forward for managing residual risk? Chowdhury SR; Rees A Curr Opin Lipidol; 2012 Oct; 23(5):509-10. PubMed ID: 22964999 [No Abstract] [Full Text] [Related]